结直肠癌干细胞中的线粒体 - 药物耐药性的目标
Mateus de Almeida Rainho1, Priscyanne Barreto Siqueira2, Ísis Salviano Soares de Amorim2
1Laboratory of Stem Cell Research, Histology and Embryology Department, Roberto Alcantara Gomes Biology Institute, State University of Rio de Janeiro, Rio de Janeiro 20550-170, Brazil.
Cancer drug resistance (Alhambra, Calif.)
|July 17, 2023
概括
结肠直肠癌干细胞 (CCSCs) 通过利用线粒体功能来驱动治疗抵抗力. 向线粒体可以克服结直肠癌 (CRC) 中的化学抵抗.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 线粒体生物学 线粒体生物学
背景情况:
- 结肠直肠癌 (CRC) 是全球癌症死亡的主要原因.
- 结肠直肠癌干细胞 (CCSCs) 有助于治疗耐药性和转移.
- 线粒体在癌细胞生存和耐药性方面发挥着至关重要的作用.
研究的目的:
- 研究线粒体在结直肠癌干细胞 (CCSC) 中的作用及其对抗药性贡献.
- 了解CCSCs逃避化疗的机制.
主要方法:
- 在CCSC中分析线粒体代谢.
- 在CCSCs中对亡调节和线粒细胞衰减的评估.
- 在CCSC中评估氧化酸化依赖性.
主要成果:
- CCSCs表现出增强的抗亡蛋白表达.
- 在CCSC中观察到菌菌率的增加,有助于生存.
- CCSCs表现出对氧化酸化用于能源生产的成.
结论:
- 线粒体变化是CCSCs对化疗的关键生存策略.
- 准CCSC中的线粒体通路为CRC提供了一个潜在的治疗策略.
- 开发针对线粒体的药物对于克服CRC化学抵抗至关重要.
相关概念视频
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Electron Transport Chain: Complex I and II
14.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.5K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K


